Superworth

Pro DEX price to free cash flow PDEX

Market value divided by free cash flow over the last twelve months, since 2015.

Today, Nov 2, 2026
17.3×
10-year median
21.5×
Against its 10-year history
34th
percentile: 0 is its lowest day, 100 its highest
10-year range
7.8× to 63.2×
Peer median
12.0×

Pro DEX's price to free cash flow is 17.3× as of Nov 2, 2026.

That is below its ten-year median of 21.5×, lower than on 66% of days in the last ten years.

Over that time it ranged from 7.8× in Feb 2018 to 63.2× in Dec 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 12.0×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far17.3×17.3×34.8×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
202314.2×14.1×14.2×
2022n/m a value too high to mean anything
202137.6×30.1×48.0×
202045.9×16.9×63.2×
201925.2×13.7×44.0×
201836.6×7.8×43.1×
20178.3×8.1×23.1×
2016n/m a value too high to mean anything
201525.3×24.8×29.8×

Against its peers

Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.

CompanyPrice to free cash flow
PDEXPro DEX17.3×
UTMDUtah Medical Products19.6×
INFUInfuSystem12.0×
EMBCEmbecta2.1×
KEQUKewaunee Scientific8.9×
TCMDTactile Systems Technology19.3×
APTAlpha Pro Tech9.6×
MOVMovado10.0×
NEPHNephrosn/m
IRMDIradimed38.9×
IARTIntegra Lifesciences12.3×
Peer median12.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Pro DEX

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.